Th1/Th2 cytokines and ICAM–1 levels post-liver transplant do not predict early rejection

Th1 derived cytokines IFN-γ and IL–2, Th2 cytokine IL–4, and ICAM–1 have been implicated in liver allograft rejection. In order to determine whether monitoring of cytokine profiles during the first days post-liver transplant can predict early rejection we measured IFN-gg, IL–2, sIL–2 receptor, IL–4...

Full description

Saved in:
Bibliographic Details
Main Authors: E. Granot, A. Tarcsafalvi, S. Emre, P. Sheiner, S. Guy, M. E. Schwartz, P. Boros, C. M. Miller
Format: Article
Language:English
Published: Wiley 2000-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1080/09629350050024366
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832564701662281728
author E. Granot
A. Tarcsafalvi
S. Emre
P. Sheiner
S. Guy
M. E. Schwartz
P. Boros
C. M. Miller
author_facet E. Granot
A. Tarcsafalvi
S. Emre
P. Sheiner
S. Guy
M. E. Schwartz
P. Boros
C. M. Miller
author_sort E. Granot
collection DOAJ
description Th1 derived cytokines IFN-γ and IL–2, Th2 cytokine IL–4, and ICAM–1 have been implicated in liver allograft rejection. In order to determine whether monitoring of cytokine profiles during the first days post-liver transplant can predict early rejection we measured IFN-gg, IL–2, sIL–2 receptor, IL–4 and ICAM–1 in 22 patients, in plasma samples obtained within 4h after liver perfusion (baseline) and between postoperative days (POD) 3–6. ICAM–1 and sIL–2R levels at POD 3–6 were significantly higher than at baseline but did not differ in presence or absence of rejection. Mean percentage increase of ICAM–1 levels was significantly lower in patients with Muromonab-C3 Orthoclone OKT3 (J.C. Health Care) (OKT3) whereas percentage increase of sIL–2R levels was higher in OKT3-treated patients. IFN-γ levels at POD 3–6 increased from baseline while IL–4 levels were unchanged. Levels of IFN-γ, IL–4 and their ratios did not correlate with rejection or immunosuppressive therapy. Thus, Th1/Th2 cytokine monitoring during the first week post-transplant does not predict early rejection and immunosuppressive therapy is the predominant factor affecting ICAM and sIL–2R levels after liver transplantation.
format Article
id doaj-art-a7a738cf487e4e6c89ecf0cfdbab13b0
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2000-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-a7a738cf487e4e6c89ecf0cfdbab13b02025-02-03T01:10:29ZengWileyMediators of Inflammation0962-93511466-18612000-01-0191353810.1080/09629350050024366Th1/Th2 cytokines and ICAM–1 levels post-liver transplant do not predict early rejectionE. Granot0A. Tarcsafalvi1S. Emre2P. Sheiner3S. Guy4M. E. Schwartz5P. Boros6C. M. Miller7Department of Paediatrics, Hadassah University Hospital, P.O. Box 12000, Jerusalem 91120, IsraelDepartment of Paediatrics, Hadassah University Hospital, P.O. Box 12000, Jerusalem 91120, IsraelDepartment of Paediatrics, Hadassah University Hospital, P.O. Box 12000, Jerusalem 91120, IsraelDepartment of Paediatrics, Hadassah University Hospital, P.O. Box 12000, Jerusalem 91120, IsraelDepartment of Paediatrics, Hadassah University Hospital, P.O. Box 12000, Jerusalem 91120, IsraelDepartment of Paediatrics, Hadassah University Hospital, P.O. Box 12000, Jerusalem 91120, IsraelDepartment of Paediatrics, Hadassah University Hospital, P.O. Box 12000, Jerusalem 91120, IsraelDepartment of Paediatrics, Hadassah University Hospital, P.O. Box 12000, Jerusalem 91120, IsraelTh1 derived cytokines IFN-γ and IL–2, Th2 cytokine IL–4, and ICAM–1 have been implicated in liver allograft rejection. In order to determine whether monitoring of cytokine profiles during the first days post-liver transplant can predict early rejection we measured IFN-gg, IL–2, sIL–2 receptor, IL–4 and ICAM–1 in 22 patients, in plasma samples obtained within 4h after liver perfusion (baseline) and between postoperative days (POD) 3–6. ICAM–1 and sIL–2R levels at POD 3–6 were significantly higher than at baseline but did not differ in presence or absence of rejection. Mean percentage increase of ICAM–1 levels was significantly lower in patients with Muromonab-C3 Orthoclone OKT3 (J.C. Health Care) (OKT3) whereas percentage increase of sIL–2R levels was higher in OKT3-treated patients. IFN-γ levels at POD 3–6 increased from baseline while IL–4 levels were unchanged. Levels of IFN-γ, IL–4 and their ratios did not correlate with rejection or immunosuppressive therapy. Thus, Th1/Th2 cytokine monitoring during the first week post-transplant does not predict early rejection and immunosuppressive therapy is the predominant factor affecting ICAM and sIL–2R levels after liver transplantation.http://dx.doi.org/10.1080/09629350050024366
spellingShingle E. Granot
A. Tarcsafalvi
S. Emre
P. Sheiner
S. Guy
M. E. Schwartz
P. Boros
C. M. Miller
Th1/Th2 cytokines and ICAM–1 levels post-liver transplant do not predict early rejection
Mediators of Inflammation
title Th1/Th2 cytokines and ICAM–1 levels post-liver transplant do not predict early rejection
title_full Th1/Th2 cytokines and ICAM–1 levels post-liver transplant do not predict early rejection
title_fullStr Th1/Th2 cytokines and ICAM–1 levels post-liver transplant do not predict early rejection
title_full_unstemmed Th1/Th2 cytokines and ICAM–1 levels post-liver transplant do not predict early rejection
title_short Th1/Th2 cytokines and ICAM–1 levels post-liver transplant do not predict early rejection
title_sort th1 th2 cytokines and icam 1 levels post liver transplant do not predict early rejection
url http://dx.doi.org/10.1080/09629350050024366
work_keys_str_mv AT egranot th1th2cytokinesandicam1levelspostlivertransplantdonotpredictearlyrejection
AT atarcsafalvi th1th2cytokinesandicam1levelspostlivertransplantdonotpredictearlyrejection
AT semre th1th2cytokinesandicam1levelspostlivertransplantdonotpredictearlyrejection
AT psheiner th1th2cytokinesandicam1levelspostlivertransplantdonotpredictearlyrejection
AT sguy th1th2cytokinesandicam1levelspostlivertransplantdonotpredictearlyrejection
AT meschwartz th1th2cytokinesandicam1levelspostlivertransplantdonotpredictearlyrejection
AT pboros th1th2cytokinesandicam1levelspostlivertransplantdonotpredictearlyrejection
AT cmmiller th1th2cytokinesandicam1levelspostlivertransplantdonotpredictearlyrejection